Shelter Pharma primarily focuses on manufacturing herbal products with a well-built presence in Human Pharma as well as Veterinary space. Shelter started with a few products about decades back. However, over a period of time, it has added products to its portfolio through its in-house R & D efforts backed by sound knowledge of Ayurveda. Shelter is present in most of the non-critical segments of Human as well as Veterinary Pharma through its well-spread portfolio. It enjoys good product acceptance and market share in the state of Gujarat. In the Human pharma segment, Shelter has a product portfolio of OTC products as well as Ethical pharma products. Similarly, Shelter has OTC and Ethical presence in the Veterinary segment. Shelter has a respectable track record of the efficacy of its products. All the products are priced very competitively considering Shelter’s target market.
The Company’s business was slowly expanded from a local presence in Himmatnagar to well spread presence in the state of Gujarat. Shelter remained a family enterprise before the incorporation of the Company with a consolidated position in Gujarat. The introduction of a new generation of promoters, set up of new companies around 2007 brought new ideas and aspirations to the business. Shelter has embarked on a major restructuring drive in line with redefined goals and objectives for last 4 years. The company has reworked its organizational structure, product portfolio, distribution network, pricing, packaging, and internal processes. It has also invested substantially in strengthening infrastructure with fresh fund infusions to improve its manufacturing capacity in Himmatnagar.
The company is also in the process of building up its management bandwidth with the planned induction of senior-level professionals in the system. It is also strengthening its R & D systems to fuel future growth in domestic as well as international market.
Objects of the Issue:
- Working Capital Requirements
- General Corporate Purposes
Shelter Pharma IPO Review
- Avoid
Shelter Pharma IPO Date & Price Band Details
IPO Open: | August 10, 2023 |
IPO Close: | August 14, 2023 |
IPO Size: | Approx ₹16.03 Crores, 3,816,000 Equity Shares |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹42 Per Equity Share |
IPO Listing on: | BSE SME |
Retail Quota: | 50% of the net offer |
NII Quota: | 50% of the net offer |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors in IPO: | Click Here |
Shelter Pharma IPO Market Lot
The Shelter Pharma IPO minimum market lot is 3000 shares with a ₹126,000 application amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 3000 | ₹126,000 |
Retail Maximum | 1 | 3000 | ₹126,000 |
S-HNI Minimum | 2 | 6000 | ₹252,000 |
Shelter Pharma IPO Dates
The Shelter Pharma IPO date is August 10 and the IPO close date is August 14. The IPO allotment date is August 18 and the IPO might list on August 23.
IPO Open Date: | August 10, 2023 |
IPO Close Date: | August 14, 2023 |
Basis of Allotment: | August 18, 2023 |
Refunds: | August 21, 2023 |
Credit to Demat Account: | August 22, 2023 |
IPO Listing Date: | August 23, 2023 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Shelter Pharma IPO Form
How to apply Shelter Pharma IPO? You can apply Shelter Pharma IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Shelter Pharma IPO in the Invest section. The other option you can apply Shelter Pharma IPO via IPO forms download via the BSE website. Check out the Shelter Pharma forms – click BSE IPO Forms download, fill and submit in your bank or with your broker.
Shelter Pharma Company Financial Report
₹ in Crores | |||
Year | Revenue | Expense | PAT |
2020 | ₹30.07 | ₹29.83 | ₹0.08 |
2021 | ₹22.49 | ₹22.31 | ₹0.04 |
2022 | ₹30.06 | ₹27.08 | ₹2.09 |
2023 9M | ₹30.12 | ₹23.35 | ₹4.94 |
Shelter Pharma IPO Valuation – FY2022
Check Shelter Pharma IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
Earning Per Share (EPS): | ₹42.54 per Equity Share |
Price/Earning P/E Ratio: | 19.55 |
Return on Net Worth (RoNW): | 23.39% |
Net Asset Value (NAV): | ₹11.37 per Equity Share |
Peer Group
- Dabur India Limited
- Emami Limited
Company Promoters
- Mr. Mustaqim Nisarahmed Sabugar
- Mr. Shakil Nisarahmed Sabugar
Shelter Pharma IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: http://www.bigshareonline.com
Shelter Pharma IPO Allotment Status
Check Shelter Pharma IPO allotment status on Bigshare website URL. Click Here
Shelter Pharma IPO Lead Managers aka Merchant Bankers
- Gretex Corporate Services Limited
Company Address
Shelter Pharma Limited
Shelter Nagar,
Near S. T. Bus Stand,
Himmatnagar -383001
Phone: 02772296038
Email: [email protected]
Website: https://shelter.co.in/
Shelter Pharma IPO FAQs
What is Shelter Pharma IPO?
When Shelter Pharma IPO will open?
What is Shelter Pharma IPO Investors Portion?
How to Apply the Shelter Pharma IPO?
How to Apply the Shelter Pharma IPO through Zerodha?
How to Apply the Shelter Pharma IPO through Upstox?
How to Apply the Shelter Pharma IPO through Paytm Money?
What is Shelter Pharma IPO Size?
What is Shelter Pharma IPO Price Band?
What is Shelter Pharma IPO Minimum and Maximum Lot Size?
What is Shelter Pharma IPO Allotment Date?
What is Shelter Pharma IPO Listing Date?
Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
Read Also:
- NTPC Green Energy IPO Subscription Status – IPO Open
- Lamosaic India IPO Subscription Status – IPO Open
- Abha Power IPO GMP, Grey Market Premium Today
- Abha Power IPO Date, Review, Price, Allotment Details
- Edelweiss Financial Services NCD October 2024 – Effective Yield 10.99% p.a.